Home All News Page 18

All News

Internet And Biotech Related News

Dennis Nguyen, Founder/Chairman/CEO of Nasdaq-listed Society Pass Inc. (Nasdaq: SOPA) to Speak at NXT...

SINGAPORE, Feb. 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Society Pass Incorporated ("SoPa”) ( Nasdaq: SOPA ), Southeast Asia’s (SEA) next generation, data-driven, loyalty, fintech and e-commerce...

Adding Principal Solar (PSWW) to Watch List.

LIVE QUOTE Principal Solar Website

The Kahner Global Cannabis & Psychedelics Investment Summit.

  Kahner Global's 8th annual Cannabis & Psychedelics...

ChatGPT, the Biggest Thing Since the Internet.

Gary and Tanner talk about racking up 2.5 million views on Instagram Reels, how ChatGPT is influencing content creation.

The Retreat of the Amateur Investors (WSJ)

A pandemic boom attracted scores of Americans seeking gains. Now that some are backing away, the markets risk losing a key...

Revive Therapeutics (RVVTF) Advancing MDMA Thermal Patch.

Two News Reports Related to Revives Upcoming Microneedle Patch Technology While we are still laser focused on Revive...
Silo Pharma, Psychedelic Stock Review, Roland Rick Perry

SILO Pharma (SILO) Gains 53%

For Now, Volatility Remains and the Traders, Seem to be Having the Most Fun. Silo Pharma Gains 53%...

Citius Pharma (CTXR). Reports Fiscal First Quarter 2023 Financial Results and Provides Business Update

$36.9 million in cash and cash equivalents as of December 31, 2022 ; runway through February 2024

Society Pass (SOPA) $1.15 Breaks Above First Line of Resistance.

If you're familiar with the term, "..the stars are aligning" here is a real life example. If you're familiar with the term,...

Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.

Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion)...

Latest article

Citius Pharmaceuticals, Inc. (CTXR) Reports Fiscal Full Year 2023 Financial Results and Provides Business...

Mino-Lok® Pivotal Phase 3 trial enrollment completed; topline data expected 2Q 2024 LYMPHIR™ BLA resubmission on track for early 2024

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...

Major Mpox Outbreak in the Democratic Republic of Congo.

As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...